These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 20529285)

  • 21. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
    Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome.
    Oemrawsingh RM; Lenderink T; Akkerhuis KM; Heeschen C; Baldus S; Fichtlscherer S; Hamm CW; Simoons ML; Boersma E;
    Heart; 2011 Jul; 97(13):1061-6. PubMed ID: 21558475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Routinely-feasible multiple biomarkers score to predict prognosis after revascularized STEMI.
    Roubille F; Samri A; Cornillet L; Sportouch-Dukhan C; Davy JM; Raczka F; Gervasoni R; Pasquie JL; Cung TT; Piot C; Macia JC; Cransac F; Leclercq F
    Eur J Intern Med; 2010 Apr; 21(2):131-6. PubMed ID: 20206886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 33 and ST2 in non-ST-elevation myocardial infarction: comparison with Global Registry of Acute Coronary Events Risk Scoring and NT-proBNP.
    Dhillon OS; Narayan HK; Quinn PA; Squire IB; Davies JE; Ng LL
    Am Heart J; 2011 Jun; 161(6):1163-70. PubMed ID: 21641364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical markers in acute coronary syndrome.
    Ramasamy I
    Clin Chim Acta; 2011 Jul; 412(15-16):1279-96. PubMed ID: 21501603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Accuracy of a New High-Sensitivity Troponin I Assay and Five Accelerated Diagnostic Pathways for Ruling Out Acute Myocardial Infarction and Acute Coronary Syndrome.
    Greenslade JH; Carlton EW; Van Hise C; Cho E; Hawkins T; Parsonage WA; Tate J; Ungerer J; Cullen L
    Ann Emerg Med; 2018 Apr; 71(4):439-451.e3. PubMed ID: 29248334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of biomarkers in acute myocardial infarction.
    Chen Y; Tao Y; Zhang L; Xu W; Zhou X
    Postgrad Med J; 2019 Apr; 95(1122):210-216. PubMed ID: 30948439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging biomarkers for acute heart conditions.
    Vasile VC; Jaffe AS
    Curr Opin Cardiol; 2014 Jul; 29(4):312-8. PubMed ID: 24806784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incremental prognostic and clinical value of multiple novel biomarkers in heart failure.
    Jackson CE; Haig C; Welsh P; Dalzell JR; Tsorlalis IK; McConnachie A; Preiss D; Anker SD; Sattar N; Petrie MC; Gardner RS; McMurray JJ
    Eur J Heart Fail; 2016 Dec; 18(12):1491-1498. PubMed ID: 27114189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction.
    Richards AM; Nicholls MG; Yandle TG; Frampton C; Espiner EA; Turner JG; Buttimore RC; Lainchbury JG; Elliott JM; Ikram H; Crozier IG; Smyth DW
    Circulation; 1998 May; 97(19):1921-9. PubMed ID: 9609085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction.
    Sabatine MS; Morrow DA; Higgins LJ; MacGillivray C; Guo W; Bode C; Rifai N; Cannon CP; Gerszten RE; Lee RT
    Circulation; 2008 Apr; 117(15):1936-44. PubMed ID: 18378613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of plasma copeptin levels and early diagnosis of acute myocardial infarction compared with troponin-T.
    Piyanuttapull S
    J Med Assoc Thai; 2013 Jan; 96(1):13-9. PubMed ID: 23720972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome.
    Brown AM; Sease KL; Robey JL; Shofer FS; Hollander JE
    Ann Emerg Med; 2007 Feb; 49(2):153-63. PubMed ID: 17084941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
    Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
    Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum S100A4 levels as a novel biomarker for detection of acute myocardial infarction.
    Gong XJ; Song XY; Wei H; Wang J; Niu M
    Eur Rev Med Pharmacol Sci; 2015 Jun; 19(12):2221-5. PubMed ID: 26166646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ST2 in emergency department chest pain patients with potential acute coronary syndromes.
    Brown AM; Wu AH; Clopton P; Robey JL; Hollander JE
    Ann Emerg Med; 2007 Aug; 50(2):153-8, 158.e1. PubMed ID: 17466411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.
    Narain VS; Gupta N; Sethi R; Puri A; Dwivedi SK; Saran RK; Puri VK
    Indian Heart J; 2008; 60(6):536-42. PubMed ID: 19276492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective validation of a modified thrombolysis in myocardial infarction risk score in emergency department patients with chest pain and possible acute coronary syndrome.
    Hess EP; Perry JJ; Calder LA; Thiruganasambandamoorthy V; Body R; Jaffe A; Wells GA; Stiell IG
    Acad Emerg Med; 2010 Apr; 17(4):368-75. PubMed ID: 20370775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study.
    Lindholm D; James SK; Gabrysch K; Storey RF; Himmelmann A; Cannon CP; Mahaffey KW; Steg PG; Held C; Siegbahn A; Wallentin L
    JAMA Cardiol; 2018 Dec; 3(12):1160-1166. PubMed ID: 30427997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome.
    Apple FS; Smith SW; Pearce LA; Murakami MM
    Clin Chem; 2009 Jan; 55(1):93-100. PubMed ID: 19028826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.